{"address1": "60 First Street", "city": "Cambridge", "state": "MA", "zip": "02141", "country": "United States", "phone": "617 465 0013", "website": "https://primemedicine.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 214, "companyOfficers": [{"maxAge": 1, "name": "Dr. Keith Michael Gottesdiener M.D., Ph.D.", "age": 70, "title": "President, CEO, Secretary & Director", "yearBorn": 1954, "fiscalYear": 2023, "totalPay": 1059212, "exercisedValue": 0, "unexercisedValue": 678214}, {"maxAge": 1, "name": "Dr. Ann L. Lee Ph.D.", "age": 62, "title": "Chief Technical Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 684782, "exercisedValue": 0, "unexercisedValue": 1773786}, {"maxAge": 1, "name": "Dr. Jeremy S. Duffield M.D., Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 680650, "exercisedValue": 0, "unexercisedValue": 45210}, {"maxAge": 1, "name": "Dr. Andrew  Anzalone M.D., Ph.D.", "age": 37, "title": "Co-Founder & Head of Prime Editing Platform", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David R. Liu Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allan  Reine M.D.", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Meredith  Goldwasser", "age": 53, "title": "Senior VP and Head of Strategy & Corporate Operations", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carman  Alenson CPA, M.B.A.", "age": 58, "title": "Senior VP of Finance & Chief Accounting Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Brown J.D., Ph.D.", "title": "Senior Vice President of Intellectual Property & Legal Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Niamh  Alix", "title": "Chief Human Resources Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.99, "open": 1.97, "dayLow": 1.78, "dayHigh": 2.105, "regularMarketPreviousClose": 1.99, "regularMarketOpen": 1.97, "regularMarketDayLow": 1.78, "regularMarketDayHigh": 2.105, "payoutRatio": 0.0, "beta": 1.853, "forwardPE": -1.2659575, "volume": 1890396, "regularMarketVolume": 1890396, "averageVolume": 1165125, "averageVolume10days": 1501520, "averageDailyVolume10Day": 1501520, "bid": 1.75, "ask": 1.82, "bidSize": 7, "askSize": 7, "marketCap": 234122384, "fiftyTwoWeekLow": 1.65, "fiftyTwoWeekHigh": 8.27, "priceToSalesTrailing12Months": 78.48554, "fiftyDayAverage": 2.435, "twoHundredDayAverage": 3.716825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 78231112, "profitMargins": 0.0, "floatShares": 60638823, "sharesOutstanding": 131161000, "sharesShort": 19406034, "sharesShortPriorMonth": 18059532, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.148, "heldPercentInsiders": 0.23906, "heldPercentInstitutions": 0.59072, "shortRatio": 14.73, "shortPercentOfFloat": 0.2843, "impliedSharesOutstanding": 131161000, "bookValue": 1.2, "priceToBook": 1.4875, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -195882000, "trailingEps": -1.65, "forwardEps": -1.41, "enterpriseToRevenue": 26.226, "enterpriseToEbitda": -0.398, "52WeekChange": -0.6922414, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.785, "targetHighPrice": 19.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.1, "targetMedianPrice": 13.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 190442000, "totalCashPerShare": 1.492, "ebitda": -196339008, "totalDebt": 40794000, "quickRatio": 5.017, "currentRatio": 5.582, "totalRevenue": 2983000, "debtToEquity": 26.637, "revenuePerShare": 0.025, "returnOnAssets": -0.51507, "returnOnEquity": -1.36875, "grossProfits": -152306000, "freeCashflow": -114572872, "operatingCashflow": -122865000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -20.25744, "financialCurrency": "USD", "symbol": "PRME", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Prime Medicine, Inc.", "corporateActions": [], "preMarketTime": 1743595205, "regularMarketTime": 1743537600, "exchange": "NGM", "messageBoardId": "finmb_1673776358", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.65, "fiftyDayAverageChangePercent": -0.26694044, "twoHundredDayAverageChange": -1.931825, "twoHundredDayAverageChangePercent": -0.5197514, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-10-20", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1666272600000, "preMarketChange": 0.035000086, "preMarketChangePercent": 1.9607892, "preMarketPrice": 1.82, "regularMarketChange": -0.20500004, "regularMarketDayRange": "1.78 - 2.105", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1165125, "fiftyTwoWeekLowChange": 0.13499999, "fiftyTwoWeekLowChangePercent": 0.08181818, "fiftyTwoWeekRange": "1.65 - 8.27", "fiftyTwoWeekHighChange": -6.4850006, "fiftyTwoWeekHighChangePercent": -0.78415966, "fiftyTwoWeekChangePercent": -69.22414, "epsTrailingTwelveMonths": -1.65, "epsForward": -1.41, "epsCurrentYear": -1.15496, "priceEpsCurrentYear": -1.545508, "longName": "Prime Medicine, Inc.", "regularMarketChangePercent": -10.30151, "regularMarketPrice": 1.785, "displayName": "Prime Medicine", "trailingPegRatio": null}